Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × niraparib × 30 days × Clear all

Sponsor

Conditions

Ovarian Neoplasms 4 Prostatic Neoplasms, Castration-Resistant 2 Prostatic Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Pancreatic Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-sensitive Prostate Cancer 1 Glioblastoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

venetoclax 20 ibrutinib 17 obinutuzumab 13 Rituximab 12 acalabrutinib 11 Specimen Handling 10 Cyclophosphamide 9 pirtobrutinib 7 Biopsy 7 zanubrutinib 6 fludarabine 6 Magnetic Resonance Spectroscopy 4 Lenalidomide 4 idelalisib 3 Vincristine 3 Prednisone 3 Doxorubicin 3 CT-P10 3 Bendamustine Hydrochloride 3 ARQ531 3 fludarabine phosphate 2 Blood Component Removal 2 tocilizumab 1 ruxolitinib 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 mirdametinib 1 letermovir 1 gamma-Globulins 1 fluarix 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡